Average Co-Inventor Count = 4.44
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pamgene Bv (4 from 16 patents)
2. Erasmus University Medical Center Rotterdam (1 from 62 patents)
3. Stichting Het Nederlands Kanker Instituut (1 from 4 patents)
4. Oslo University Hospital (1 from 1 patent)
5. Leiden University Medical Center (15 patents)
6. Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg (11 patents)
4 patents:
1. 11802315 - Method for predicting the response of non-small-cell lung carcinoma patients to a medicament
2. 8962268 - Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)
3. 8962267 - Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy
4. 8617836 - Method for predicting the response of locally advanced rectal cancer to chemoradiotherapy